ロード中...
Effect of Teneligliptin versus Sulfonylurea on Major Adverse Cardiovascular Outcomes in People with Type 2 Diabetes Mellitus: A Real-World Study in Korea
BACKGROUND: Results regarding the cardiovascular (CV) effects of dipeptidyl peptidase-4 (DPP-4) inhibitors are inconsistent. This study aimed to assess the effects of teneligliptin, a DPP-4 inhibitor, on the risk of major CV outcomes in type 2 diabetes mellitus (T2DM) patients compared to sulfonylur...
保存先:
| 出版年: | Endocrinol Metab (Seoul) |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Korean Endocrine Society
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7937854/ https://ncbi.nlm.nih.gov/pubmed/33677929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2020.777 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|